Walgreens Boots Alliance Dirección

Dirección controles de criterios 1/4

El CEO de Walgreens Boots Alliance's es Tim Wentworth, nombrado en Oct 2023, tiene una permanencia de menos de un año. posee directamente un 0.068% de las acciones de la empresa, con un valor de R$55.11M. La antigüedad media del equipo directivo y de la junta directiva es de 0.8 años y 3.5 años, respectivamente.

Información clave

Tim Wentworth

Chief Executive Officer (CEO)

n/a

Compensación total

Porcentaje del salario del CEO	n/a
Permanencia del CEO	less than a year
Participación del CEO	0.07%
Permanencia media de la dirección	less than a year
Promedio de permanencia en la Junta Directiva	3.6yrs

Actualizaciones recientes de la dirección

Recent updates

CEO

Tim Wentworth (63 yo)

less than a year

Permanencia

Mr. Timothy C. Wentworth, also known as Tim, served as Director of Ushur, Inc. since February 2022. He served as the Chief Executive Officer of Evernorth at Evernorth Health, Inc. (formerly known as Expres...

Equipo directivo

Nombre	Posición	Permanencia	Compensación	Propiedad
Stefano Pessina	Executive Chairman of the Board	12.1yrs	US$7.57m	0.076% $ 57.9m
Manmohan Mahajan	Executive VP & Global CFO	less than a year	US$1.83m	0.019% $ 14.8m
Ornella Barra	Executive VP & COO of International	3.1yrs	US$5.43m	0.24% $ 180.1m
Timothy Wentworth	CEO & Director	less than a year	sin datos	0.068% $ 51.8m
Todd Heckman	Senior VP	less than a year	sin datos	0.0010% $ 764.2k
Neal Sample	Executive VP & Chief Information Officer	less than a year	sin datos	sin datos
Tiffany Kanaga	Vice President of Global Investor Relations	no data	sin datos	sin datos
Matthew D'Ambrosio	Senior VP and Global Chief Compliance & Ethics Officer	no data	sin datos	sin datos
Lanesha Minnix	Executive VP & Global Chief Legal Officer	less than a year	sin datos	sin datos
Elizabeth Burger	Executive VP & Chief Human Resources Officer	no data	sin datos	sin datos
Liyue Wu	Head of M&A - Asia	no data	sin datos	sin datos
Tracey Brown	Executive VP	2.5yrs	sin datos	0.0030% $ 2.3m

0.8yrs

Permanencia media

52.5yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de WGBA34 no se considera experimentado ( 0.8 años antigüedad media), lo que sugiere un nuevo equipo.

Miembros de la Junta

Nombre	Posición	Permanencia	Compensación	Propiedad
Stefano Pessina	Executive Chairman of the Board	12.1yrs	US$7.57m	0.076% $ 57.9m
Timothy Wentworth	CEO & Director	less than a year	sin datos	0.068% $ 51.8m
Ginger Graham	Lead Independent Director	14.1yrs	US$366.85k	0.00025% $ 191.1k
Valerie Jarrett	Independent Director	3.6yrs	US$300.00k	0.00052% $ 397.4k
Nancy Schlichting	Independent Director	17.6yrs	US$319.97k	0% $ 0
John Lederer	Independent Director	9.1yrs	US$315.00k	0.0058% $ 4.4m
Bryan Hanson	Independent Director	1.6yrs	US$84.62k	0.0011% $ 855.9k
Janice Babiak	Independent Director	12.1yrs	US$325.00k	0.00014% $ 107.0k
Inderpal Bhandari	Independent Director	1.7yrs	US$115.29k	0.00035% $ 267.5k
Thomas Polen	Director	less than a year	US$14.13k	0.00020% $ 152.8k
Robert Huffines	Independent Director	less than a year	sin datos	sin datos

3.6yrs

Permanencia media

65yo

Promedio de edad

Junta con experiencia: La junta directiva de WGBA34 se considera experimentada (3.5 años de antigüedad promedio).

Walgreens Boots Alliance Dirección

Dirección controles de criterios 1/4

Información clave

Actualizaciones recientes de la dirección

Walgreens Boots Alliance, Inc. Names Lanesha Minnix as Executive Vice President and Global Chief Legal Officer

Walgreens Boots Alliance, Inc. Announces Executive Changes

Walgreens Boots Alliance, Inc. Elects Robert L. Huffines to Board of Directors

Walgreens Boots Alliance, Inc., Annual General Meeting, Jan 25, 2024

Walgreens Boots Alliance Names Neal Sample Executive Vice President and Chief Information Officer

Walgreens Boots Alliance, Inc. Appoints Tim Wentworth as Chief Executive Officer, Effective October 23, 2023

Recent updates

Walgreens Boots Alliance, Inc. Declares Quarterly Dividend, Payable on June 12, 2024

Wisner Baum Files Multiple Class Actions Alleging Several Companies Sold Benzoyl Peroxide Acne Products Without Warning Consumers That They Contain Unsafe Levels of Benzene, a Potent Human Carcinogen

Walgreens Boots Alliance, Inc. to Report Q2, 2024 Results on Mar 28, 2024

Walgreens Boots Alliance, Inc. Names Lanesha Minnix as Executive Vice President and Global Chief Legal Officer

Walgreens Boots Alliance, Inc. Announces Executive Changes

Walgreens Boots Alliance, Inc. Elects Robert L. Huffines to Board of Directors

Walgreens Reportedly Explores $4 Billion-Plus Sale of Shields Health

Walgreens Boots Alliance, Inc. Declares Quarterly Dividend, Payable on March 12, 2024

The Shareholder Commons, Inc Files a Notice of Exempt Solicitation to Walgreens Boots Alliance, Inc

Walgreens Boots Alliance, Inc., Annual General Meeting, Jan 25, 2024

Walgreens Boots Alliance, Inc. to Report Q1, 2024 Results on Jan 04, 2024

Walgreens Boots Alliance Names Neal Sample Executive Vice President and Chief Information Officer

Walgreens Boots Alliance, Inc. Declares Quarterly Dividend, Payable on December 12, 2023

Walgreens Boots Alliance, Inc. Provides Earnings Guidance for the Fiscal Year 2024

Walgreens Boots Alliance, Inc. Appoints Tim Wentworth as Chief Executive Officer, Effective October 23, 2023

Walgreens Boots Alliance, Inc.(NasdaqGS:WBA) dropped from S&P 100

Dicello Levitt Files Lawsuit Against Kenvue, Procter & Gamble, Glaxosmithkline, and Walgreens

Walgreens Boots Alliance, Inc. Announces CEO Changes

Walgreens Boots Alliance, Inc. Announces Departure of James Kehoe as Executive Vice President

Walgreens Boots Alliance Declares Quarterly Dividend, Payable on September 12, 2023

Walgreens Boots Alliance, Inc. (NasdaqGS:WBA) entered into an agreement to acquire 120 pharmacies in Texas, Louisiana and Arkansas from Brookshire Grocery Company.

An unknown buyer acquired 6.004471% stake in Option Care Health, Inc. (NasdaqGS:OPCH) from Walgreens Boots Alliance, Inc. (NasdaqGS:WBA) for approximately $330 million.

Walgreens Boots Alliance, Inc. to Report Q3, 2023 Results on Jun 27, 2023

Walgreens Boots Alliance Declares Quarterly Dividend, Payable on March 10, 2023

Walgreens Reportedly Weighs $2 Billion Sale of Pharmacy Automation Unit

Walgreens Boots Alliance, Inc. Provides Sales Guidance for Fiscal 2023

Walgreens Boots Alliance, Inc. to Report Q1, 2023 Results on Jan 05, 2023

Walgreens Boots Alliance, Inc., Annual General Meeting, Jan 26, 2023

Walgreens Boots Alliance, Inc., Annual General Meeting, Jan 26, 2023

Walgreens Boots Alliance, Inc. Announces Resignation of William Foote, the Board Lead Independent Director

Walgreens Boots Alliance, Inc. Declares Quarterly Dividend, Payable on December 12, 2022

Walgreens Boots Alliance, Inc. (NasdaqGS:WBA) entered into a definitive agreement to acquire remaining 45% stake in CareCentrix, Inc. for approximately $390 million.

John Standley to Leave as Executive Vice President of Walgreens Boots Alliance, Inc. on November 1, 2022

Walgreens Boots Alliance, Inc. (NasdaqGS:WBA) entered into an agreement to acquire additional 30% stake in Shields Specialty Pharmacy Holdings, LLC from Welsh, Carson, Anderson & Stowe, Jack Shields & others for approximately $1.4 billion.

Walgreens Boots Alliance, Inc. to Report Q4, 2022 Results on Oct 13, 2022

Walgreens Boots Alliance, Inc. Announces Executive Appointments

Walgreens Boots Alliance, Inc. (NasdaqGS:WBA) completed the acquisition of a 55% stake in CareCentrix, Inc.

Walgreens Boots Alliance, Inc. (NasdaqGS:WBA) completed the acquisition of a 55% stake in CareCentrix, Inc.

Walgreens Boots Alliance, Inc. Names Alethia Jackson Senior Vice President, ESG and Chief DEI Officer

Walgreens Boots Alliance, Inc. Announces Resignation of David J. Brailer as Member of the Board of Directors

Jnd Legal Administration Announces A Class Action Lawsuit in the U.S. District Court for the District of Arizona Against Defendants Theranos, Inc., Walgreens Boots Alliance, Inc. and Walgreen Arizona Drug Company

Walgreens Boots Alliance Increases Quarterly Dividend, Payable September 9, 2022

Walgreens Boots Alliance Concludes Strategic Review and Decides to Retain Ownership of Its Successful Boots Business

Walgreens Launches Clinical Trial Business to Address Industrywide Access and Diversity Challenges and Redefine Patient Experience

Walgreens Boots Alliance, Inc. to Report Q3, 2022 Results on Jun 30, 2022

Walgreens Reportedly Gives A Few Extra Days for Bidders to Firm Up Offers

An unknown buyer acquired 2.9% stake in AmerisourceBergen Corporation (NYSE:ABC) from Walgreens Boots Alliance, Inc. (NasdaqGS:WBA) for $900 million.

Walgreens Boots Alliance, Inc. Reaches Opioid Settlement with State of Florida

Walgreens Reportedly Sets Deadline for Bids in Boots Auction

Reliance Industries Reportedly Studying Possible Bid for Walgreens' Boots Chain

Private Equity Giant Reportedly Abandons Boots Takeover

Walgreens Boots Alliance, Inc. Appoints Steven J. Shulman to Its Board of Directors

Walgreens Boots Alliance Declares Quarterly Dividend, Payable on March 11, 2022

Bain and CVC Reportedly to Team Up for Boots Bid

Oak Street Real Estate Capital, LLC acquired 1.68-acre property at 3600 Winter Garden Vineland Road in Winter Garden from Walgreens Boots Alliance, Inc. (NasdaqGS:WBA) for $5.2 million.

PLx Pharma Inc.’s VAZALORE to Launch in over 8,000 Walgreens Stores Nationwide in August

Walgreens Boots Alliance, Inc.(NasdaqGS:WBA) dropped from Russell 1000 Defensive Index

Walgreens Boots Alliance, Inc. to Report Q2, 2021 Results on Mar 31, 2021

Walgreens and Uber Technologies, Inc. Enters into an Agreement to Help Drive Equitable Access to COVID-19 Vaccines Among Underserved Communities

Walgreens Boots Alliance, Inc Announces Management Changes Effect from March 15, 2021

Walgreens Boots Alliance Announces Executive Changes

Walgreens Expands Financial Services Business Strategy, in Partnership with Synchrony and Mastercard

Walgreens Begins Administration of Pfizer’s COVID-19 Vaccine in Long-Term Care Facilities

Verizon Business and Walgreens Boots Alliance Partner to Power Digital Customer Experiences at Walgreens Stores Nationwide

Walgreens Boots Alliance, Inc. to Report Q1, 2021 Results on Jan 07, 2021

Walgreens and VillageMD to Open the Next 40 Full-Service Primary Care Clinics

Walgreens Boots Alliance and McKesson Corporation the Formation of German Wholesale Joint Venture

Walgreens Boots Alliance, Inc. Appoints Valerie Jarrett to Its Board of Directors

Walgreens Boots Alliance, Inc. to Report Q4, 2020 Results on Oct 15, 2020